Delivers data-driven fleet orchestration solutions to optimize and automate fleet and leasing management for superior efficiency.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Ridecell is a leading provider of fleet orchestration solutions for fleet and leasing management. The company’s Ridecell 360 platform delivers data-driven intelligence and automation to modernize and optimize fleet businesses, uncovering blind spots and orchestrating improvements throughout the vehicle lifecycle to enable a superior customer experience.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Ridecell Management Team
Investors
Activate Capital
Ally Financial Inc.; DBA: Ally Ventures
BMW i Ventures
BNP Paribas
Cox Enterprises, Inc.
DENSO
DENSO International America
Gokul Rajaram
Individuals
Initialized Capital
Khosla Ventures
LG Technology Ventures
Mark Platshon
Mehul Nariyawala
Michael Granoff
Mitsui USA
Navneet Dalal
Sony Innovation Fund
Ridecell Valuations & Financials
View real-time NPM data on Ridecell stock including daily Ridecell stock price estimates, valuation history, and historical share price information. Access Ridecell financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Ridecell pricing across six independent market signals. Looking for private company due diligence data sources on Ridecell? Get in touch to learn more.
Similar Companies
like Ridecell
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Myeloid Therapeutics
Healthcare & Life Sciences
Develops targeted immunotherapies for cancer and autoimmune diseases using proprietary technology to enhance immune system responses.
Medbelle
Coordinates private surgical journeys to streamline patient communication and administrative hospital logistics.
EXUMA Biotech
Healthcare & Life Sciences
Develops gene vector delivery platforms to make cell and gene therapies more accessible, cost-effective, and safer for patients.
Angitia Biopharmaceuticals
Develops innovative biologic therapies for serious musculoskeletal diseases like osteoporosis, osteogenesis imperfecta, and spinal fusion.
Foresight
Enterprise Software
A unified data platform for private market investors, integrating pre- and post-deal data into a single source of truth.
Scalable Capital
Enables self-directed trading and offers professionally managed portfolios, tailored to users' risk profiles and investment objectives.
VoiceCare AI
Healthcare & Life Sciences
Voice agent automating provider–payer calls that streamlines authorizations, claims, and verifications with detailed documentation.
Suzy
Delivers real-time consumer insights to help brands make smarter, faster decisions across marketing, product, sales, and strategy.
FAQ
We have answers
Ridecell stock does not trade on public stock exchanges. Ridecell stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Ridecell stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Ridecell Stock does not trade on public stock exchanges. In order to sell Ridecell shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Ridecell does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Ridecell share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Ridecell stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Ridecell stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Ridecell stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Ridecell is a private company and has not had an IPO. There is currently no Ridecell IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Ridecell IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
